ArticleFrontiers in pharmacology2025
Comparative safety analysis of bevacizumab and alkylating agent in glioblastoma management - What have we learned recently?
Zhizhao Qu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it